Mr Mrs Miss Ms Dr Other

Mr
Craig
Thomson

Partner & Patent Attorney

Glasgow Office Aberdeen Office Westport Office Dublin Office

Life sciences

Telephone. +44(0) 141 229 5800
Mobile. +44(0) 7889088054
Email. [email protected]
UPC Representative
Our team of specialist European patent litigators, oppositions specialists and patent attorneys bring together an extensive depth of legal and technical knowledge and are qualified to represent you in the UPC.
Vcard
Linkedin

Experience

Craig is recognised for providing pragmatic, commercially focused advice to clients in the biotechnological, pharmaceutical, chemical and MedTech sectors. As well as patent drafting and prosecution, Craig advises on the development of company-wide IP strategies, funding/acquisition due-diligence, and aggressive/defensive strategies in relation to third-party IP.

Having worked closely with multi-national corporations, Craig understands the challenges associated with efficiently prosecuting large multi-national patent portfolios, whilst keeping them relevant to the business. He values this experience as it helps him to provide expert guidance to SMEs as they grow or prepare for acquisition.
Whilst part of Craig’s focus is ensuring that technical aspects of each invention is accurately captured in a patent, he understands that the value of IP can only be fully realised after understanding the commercial goals of a business, and how IP can best be exploited to help underpin those goals. It is therefore important for him to understand more generally his client’s business; enabling him to provide them with a more broad-ranging, effective and valuable set of solutions. Industry sectors for which Craig has considerable knowledge of include those concerned with the microbiome, food, formulations, anti-infectives, diagnostics and MedTech.

Craig has a proven track record of providing successful outcomes for clients, both in a wide-range of legal proceedings (including opposition, entitlement, and USPTO interviews) and in successful IP-license/assignment deals involving patents that he both drafted and prosecuted to grant. He has co-written an amicus curiae (filed with the US Supreme Court for Sequenom v Ariosa), and has assisted many clients to successfully obtain investment, including listing on AIM.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
Europe
Ireland

BSC

Physiology and Pharmacology

MSC

Management of Intellectual Property

Recognition

IAM Patent 1000: The World’s Leading Patent Professionals 2020

“Craig Thomson, who is well versed in all things biotechnological and pharmaceutical, particularly therapeutic and diagnostic inventions. He has a “phenomenal ability to quickly grasp the key concepts in an invention and tease out the most inventive aspects so as to file the strongest possible patents. He is always on hand to guide patent strategy and has incredible patience when explaining the intricacies of the prosecution process. He is also ridiculously good fun to work with!” “He takes a practical, business-oriented approach, focusing on what will drive value in the European market in a way that enables informed decision making. In view of technological convergence, his technical versatility is invaluable.””

View recognition online

IAM Patent 1000: The World’s Leading Patent Professionals 2019

“Taking the reins on this initiative is Craig Thomson, an experienced handler of biotech, pharmaceutical, chemical and medical innovations. Thomson is a seasoned prosecutor and serves up trenchant advice on IP strategy in connection with technology-driven deals and enforcement issues; the broad ambit of his practice has helped him develop a refined commercial sense.”

Publications

HGF & Shiga Webinar Recording: When "Please amend to fall into line with the granted claims in the US" might not work in Europe and Japan

View publication online

Leader's League Rankings 2023

View publication online

IP Stars 2023

View publication online

HGF continues to grow across Europe with office relocation and expansion in the Island of Ireland

View publication online

IAM Patent 1000 2022

View publication online

The Microbiome Times: ELIGO v SNIPR: a reflection on IP strategies in a competitive environment

View publication online

KTN Microbiome Strategic Roadmap

View publication online

IAM Patent 1000 2020

View publication online

The Vedanta Opposition: A healthy sign of a maturing industry

View publication online

IAM Patent 1000 2019

View publication online

The Vedanta Opposition: A healthy sign of a maturing industry

Download publication PDF

Securing Commercial Advantage Through Innovations in Microbiome Therapeutic Production

View publication online

Download publication PDF

Validity Attack on US Patent for Bifidobacetrium ComboTherapy: What can we learn?

View publication online

Download publication PDF

LSIPR: Will Big Pharma Get The Bug For Microbiome Therapies?

View publication online

Conferences: 2023

June 29th 2023

Dublin IP and R&D Summit

Speaker

Event details

Conferences: 2022

October 22nd 2022

BIONABU Health Entrepreneurship and Innovation Summit 2022

Speaker

Event details

Conferences: 2021

October 26th 2021

9th Microbiome R&D and Business Collaboration Forum: Europe

Speaker

Event details

October 21st 2021

Medical Technology Ireland Conference 2021

Speaker

Event details

October 4th 2021

IPBC Europe 2021

Speaker

Event details

March 24th 2021

Animal Microbiome Conference 2021

Speaker

March 3rd 2021

Animal Microbiome Congress 2021

Speaker

Event details

January 27th 2021

IAM webinar: Preparing for the IP due diligence checklist of the future for microbiome innovation

Speaker

Event details

January 14th 2021

HGF IP in Healthcare Virtual Conference 2021

Speaker

Event details

Conferences: 2020

October 15th 2020

4th Microbiome: Recent Developments, Regulatory, Quality and Commercialization Summit

Speaker

Event details

October 15th 2020

Microbiome Movement - Maternal & Infant Health Summit 2020

Speaker

Event details

September 8th 2020

Sustainable Protein Production and Animal Microbiome Virtual Summit 2020

Speaker

Event details

September 1st 2020

ONE Life Sciences Leadership Forum 6

Speaker

Event details

July 8th 2020

Webinar: Attracting big pharma to the Microbiome field

Speaker

Event details

April 24th 2020

Translational Microbiome Conference 2020

Speaker

Event details

Conferences: 2019

September 26th 2019

Medical Technology Ireland - Galway Racecourse

Speaker

Event details

June 3rd 2019

2019 BIO International Convention - Philadelphia

Attended

Event details

CSR

Craig provides the annual lecture, “Capturing, Protecting and Exploiting Intellectual Property in Business”, on the Masters Course for “Management of Innovation and Creativity” at Glasgow Caledonian University.

As IP lead, Craig is part of the Microbiome Innovation Network, part of the KTN, whos aims are to accelerate the commercialisation of microbiome-based products and services in the UK and create a vibrant community by connecting industry and academia. Craig also wrote the IP section for the Networks Roadmap document for the industry (https://ktn-uk.org/agrifood/microbiome/).

Related News

Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Basics of trade mark protection - National and European perspectives

HGF is pleased to invite you to our upcoming German speaking seminar on “Fundamentals of trade mark protection: National and European Perspectives” in Salzburg and Dresden. The seminar will cover …

Event details

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

How to Use IP Strategy to Tip the Odds in Your Favour

Porter’s Five Forces model [1] is just one example of a convenient model for exploring and understanding the forces at play in a competitive marketplace. Michael Porter’s Five Forces model …

Read article

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event details
Event - 29th November 2023

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback - law and practice in Europe and Japan

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …

Event details

Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us